Taisho Pharmaceutical is a finished-dose manufacturer based in Japan. It appears in 108 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with BPOM (ID), DH (HK) and NPRA (MY). Its GMP standing is certified by HSA (SG).
| Site | FDA FEI |
|---|---|
| KOTA DEPOK, Indonesia | Not on file |
| -, Indonesia | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| BPOM (ID) | 53 | None |
| DH (HK) | 53 | None |
| NPRA (MY) | 2 | None |
| HSA (SG) | None | 2 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Taisho Pharmaceutical comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.